Evidence map›Paper›PMID 29715444›Full record

ReviewBrain research2018

Dynamic duo - FMRP and TDP-43: Regulating common targets, causing different diseases.

Diana Ferro, Stephen Yao, Daniela C Zarnescu

Abstract readReview
In one paragraph

Review in Brain research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Diana FerroDepartment of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, United States.
Stephen YaoDepartment of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, United States.
Daniela C ZarnescuDepartment of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, United States; Department of Neuroscience, University of Arizona, Tucson, AZ, United States; Department of Neurology, University of Arizona, Tucson AZ, United States. Electronic address: zarnescu@email.arizona.edu.
University of Arizona · US

Funding

Translation dysregulation in neurodegenerationR01NS091299 · NINDS · UNIVERSITY OF ARIZONA · PI DANIELA C ZARNESCU · 2015 to 2026
$3.4M
Translation dysregulation in neurodegenerationRF1NS091299 · NINDS · UNIVERSITY OF ARIZONA · PI ZARNESCU, DANIELA C · 2022 to 2022
$2.0M
NINDS NIH HHS R01 NS091299NINDS NIH HHS RF1 NS091299
6 · The paper itself

Abstract

RNA binding proteins play essential roles during development and aging, and are also involved in disease pathomechanisms. RNA sequencing and omics analyses have provided a window into systems level alterations in neurological disease, and have identified RNA processing defects among notable disease mechanisms. This review focuses on two seemingly distinct neurological disorders, the RNA binding proteins they are linked to, and their newly discovered functional relationship. When deficient, Fragile X Mental Retardation Protein (FMRP) causes developmental deficits and autistic behaviors while TAR-DNA Binding Protein (TDP-43) dysregulation causes age dependent neuronal degeneration. Recent findings that FMRP and TDP-43 associate in ribonuclear protein particles and share mRNA targets in neurons highlight the critical importance of translation regulation in synaptic plasticity and provide new perspectives on neuronal vulnerability during lifespan.

Indexed as

AnimalsDisease Models, AnimalDNA-Binding ProteinsFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansNeuronal PlasticityNeuronsProtein BiosynthesisReceptors, Metabotropic GlutamateRibonucleoproteinsRNA, MessengerSignal TransductionDNA-Binding ProteinsFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1metabotropic glutamate receptor type 1Receptors, Metabotropic GlutamateRibonucleoproteinsRNA, MessengerTARDBP protein, humanAmyotrophic lateral sclerosisFMRPFragile X syndromeFrontotemporal dementiamRNA targetsRNA binding proteinsTDP-43

Identifiers

PMID29715444
PMCPMC5997554
OpenAlexW2800482962

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.